Effect of Erythropoietin in patients with acute myocardial infarction: five-year results of the REVIVAL-3 trial
Erythropoietin (EPO) has been suggested to promote cardiac repair after MI.
You may also like
Perfusion.com Cardiovascular News Roundup: <br>September 15, 2022</br>
Weekly roundup of interesting reads for the perfusion community, this week including new reviews, COVID trials, transplant news, and interesting findings on blood groups.
2 min read
Pain and Inflammatory Response following Off-Pump Coronary Artery Bypass Grafting
This article reviews the literature regarding inflammation and pain following cardiac surgery
1 min read